O'Shaughnessy Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

O'Shaughnessy Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.63M	Buy	567,492 +153,473	+37%	+$2.45M	0.04%	399
2026 Q1	$6.14M	Buy	414,019 +27,175	+7%	+$397K	0.03%	474
2025 Q4	$6.17M	Buy	386,844 +254,307	+192%	+$3.6M	0.03%	453
2025 Q3	$1.46M	Buy	132,537 +111,516	+530%	+$1.22M	0.01%	964
2025 Q2	$178K	Buy	21,021 +431	+2%	+$3.46K	﹤0.01%	1854
2025 Q1	$166K	Buy	20,590 +6,018	+41%	+$48.8K	﹤0.01%	1811
2024 Q4	$131K	Buy	14,572 +298	+2%	+$2.43K	﹤0.01%	1823
2024 Q3	$102K	Buy	+14,274	New	+$88.5K	﹤0.01%	1799

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

O'Shaughnessy Asset Management's AUPH Position: Q2 2026 in Review

O'Shaughnessy Asset Management increased its Aurinia Pharmaceuticals (AUPH) stake by 37% in Q2 2026, buying an estimated $2.45M and bringing the position to 567,492 shares worth $9.63M. The position accounts for 0.04% of the portfolio, ranked #399.

O'Shaughnessy Asset Management first reported a position in AUPH in Q3 2024 and has held it in 8 quarters since. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

O'Shaughnessy Asset Management held 567,492 shares of Aurinia Pharmaceuticals worth $9.63M as of Q2 2026.
O'Shaughnessy Asset Management bought 153,473 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $2.45M.
Aurinia Pharmaceuticals made up 0.04% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #399 holding.
O'Shaughnessy Asset Management first reported a position in Aurinia Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.